First Choise Theraphy Service is categorized under Medical Examinations-Insurance in Metuchen, NJ and active since 2005.
First Choise Theraphy Service was established in 2005, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Medical Examinations-Insurance business, which does work in the B2C market, and is classified as a Medical Examinations-Insurance, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Frank Slanagan at the company’s single location by writing to 237 Bridge St, Metuchen, New Jersey NJ 08840 or by phoning (732) 516-1177. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | First Choise Theraphy Service |
| Contact Person: | Frank Slanagan |
| Address: | 237 Bridge St, Metuchen, New Jersey 08840 |
| Phone Number: | (732) 516-1177 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Examinations-Insurance |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
First Choise Theraphy Service was started in 2005 to provide professional Medical Examinations-Insurance under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Frank Slanagan for inquiries that concern First Choise Theraphy Service by calling the company number (732) 516-1177, as your correspondence is most welcome. Additionally, the physical location of the single location of First Choise Theraphy Service can be found at the coordinates 40.539014,-74.37584 as well as the street address 237 Bridge St in Metuchen, New Jersey 08840.
For its online presence, you may visit First Choise Theraphy Service’s website at and engage with its social media outlets through on Twitter and on Facebook.